SARS-CoV-2 antibodies prevalence in the Republic of Congo in mid-2021.
FR Niama, F Koukouikila-Koussounda… - IJID Regions …, 2022 - europepmc.org
Objectives To estimate the seroprevalence of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) antibodies in the general population in the Republic of Congo …
coronavirus-2 (SARS-CoV-2) antibodies in the general population in the Republic of Congo …
Consideraciones sobre la hipótesis de la reacción cruzada heterogénea COVID/dengue, e inmunidad celular contra COVID-19
JM Karla Cardenas, AL Trejo Albuerne - 2022 - 192.100.164.85
El 31 de diciembre de 2019, la Comisión Municipal de Salud de Wuhan (provincia de
Hubei, China), notifica acerca de un conglomerado de casos de neumonía en la ciudad …
Hubei, China), notifica acerca de un conglomerado de casos de neumonía en la ciudad …
Transmission model Transmission model overview
S Orangi - gh.bmj.com
The dynamics of SARS-CoV-2 transmission in each of the 47 Kenyan counties were
assumed to follow a dynamic model adapted from a previous model;[1] here we extend the …
assumed to follow a dynamic model adapted from a previous model;[1] here we extend the …
[PDF][PDF] SARS-CoV-2 ANTIBODY CORRELATES AMONG PEOPLE WHO INJECT DRUGS LIVING WITH AND WITHOUT HIV IN KENYA
S DOSHI - croiconference.org
SARS-Cov-2 antibody prevalence among PWID and partners was 30.9%. Page 1 SARS-CoV-2
ANTIBODY CORRELATES AMONG PEOPLE WHO INJECT DRUGS LIVING WITH AND …
ANTIBODY CORRELATES AMONG PEOPLE WHO INJECT DRUGS LIVING WITH AND …